Pot Stocks to Watch-THC
Therapeutics, Inc. (THCT)
April 26, 2019 -- InvestorsHub NewsWire -- Microcap Speculators
-- With cannabis companies continuing to help investors make large
gains, we’re focusing on a few today.
One cannabis company, THC Therapeutics, Inc. (USOTC:
THCT), Very recently, announced that it has
received patent protection for the dHydronator®, which can reduce
moisture content of cannabis to 10% in only 10-14 hours
(normally it takes up to 14 days). The US patent office
accepted ALL 20 claims for The dHydronator®.
The dHydronator® also destroys harmful surface contaminants
& pathogens. The term of the patent provides 20 years of
protection on the scalable intellectual property for the
dHydronator®. This is big news from
THCT.
Today we are highlighting: THC Therapeutics, Inc. (USOTC:
THCT), MJardin Group, Inc. (MJARF), Village
Farms International, Inc. (NASDAQ:
VFF), Cresco Labs Inc. (USOTC:
CRLBF), and Origin House (USOTC:
ORHOF).
THC Therapeutics, Inc. (USOTC:
THCT) (Market Cap: $180.987M; Share Price:
$13.55) has developed a sanitizing herb dryer, The
dHydronator®. Their laboratory-proven product is specifically
designed for drying and sanitizing freshly harvested cannabis and
herbs. THCT’s product has been tested by two
independent laboratories. The testing covered over 6 strains and 9
independent tests to confirm the findings. Over the 9
tests and 6 strains, there was a 4% average increase of THC-A*.
The US patent office has accepted ALL 20 claims for The
dHydronator®. The company has received full patent
protection for the dHydronator®. Start your research today
on THCT.
_________
MJardin Group, Inc. (MJARF) (Market Cap: $142.127M;
Share Price: $1.83), a leader in cannabis production,
announced the completion of an Agreement (the “Agreement”), whereby
the Nova Scotia Mi’kmaq First Nations (“Mi’kmaq”) will own a 51%
stake in AtlantiCann Medical Inc. (“AMI”). As a result of the
Agreement, MJardin and the Halef Group will own 39% and 10% of AMI,
respectively. In connection with the partnership formed under
the Agreement, MJardin, the Mi’kmaq and the Halef Group are
contemplating expansion of their relationship, including
retail.
MJardin is a global cannabis management platform with extensive
experience in cultivation, processing, distribution and
retail. For over 10 years, MJardin has refined cultivation
methodologies, developed state of the art facilities and
implemented vertical integration for and on behalf of license
owners. MJardin is based in Denver, Colorado and Toronto,
Canada.
_________
Village Farms International, Inc. (NASDAQ:
VFF) (Market Cap: $568.341M; Share Price:
$11.62) announced recently that its 50%-owned joint
venture for large-scale, low-cost, high-quality cannabis
production, Pure Sunfarms, has exercised its option on the existing
1.1 million square foot Delta 2 greenhouse facility currently owned
by Village Farms in Delta, British Columbia. The Delta 2
facility is a newer, nearly identical "sister" facility immediately
adjacent to the 1.1 million square foot Delta 3 greenhouse
facility, which is already one of the largest cannabis production
operations in the world. The addition of the Delta 2
greenhouse operation doubles Pure Sunfarms' total production area
to 2.2 million square feet and, with conservatively targeted annual
production of approximately 75,000 kilograms of dried cannabis,
doubles its annual cannabis production potential to approximately
150,000 kilograms.
Village Farms is one of the largest and longest-operating
vertically integrated greenhouse growers in North America and the
only publicly traded greenhouse produce company in Canada.
Together with its subsidiaries, it produces, markets, and
distributes greenhouse-grown tomatoes, bell peppers, and cucumbers
in North America. The company operates in two segments,
Produce Business and Energy Business. It also owns and
operates a 7.0-megawatt power plant that generates and sells
electricity to British Columbia Hydro and Power Authority.
_________
Cresco Labs Inc. (USOTC:
CRLBF) (Market Cap: $467.439M; Share Price: $12.94)
and CannaRoyalty Corp. d/b/a Origin House
(USOTC:
ORHOF) (Market Cap: $608.258M; Share Price:
$9.10) announced a major deal in April that they have
entered into a definitive agreement (the "Agreement") pursuant to
which Cresco Labs will acquire all of the issued and outstanding
shares of Origin House (the "Origin House Shares") (the
"Transaction"). Under the terms of the Agreement, holders of
common shares of Origin House will receive 0.8428 subordinate
voting shares of Cresco Labs (the "Cresco Labs Shares") for each
Origin House Share (the "Exchange Ratio"). The transaction
represents a total consideration of approximately C$1.1 billion on
a fully-diluted basis. The transaction represents the largest
public company acquisition in the history of the U.S. cannabis
industry. The combined entity will be: one of the largest
vertically-integrated multi-state cannabis operators in the United
States, a leading North American cannabis company by footprint, and
one of the largest cannabis brand distributors. According to their
press release “the combination of Cresco Labs and Origin House will
result in the premier distribution company serving California, the
largest cannabis market in the world.”
Cresco Labs, based in Chicago, is a leading U.S. cannabis
company with experienced management, access to capital and a
demonstrated growth strategy. As a differentiated grower,
processor and retailer of premium cannabis operating across the
United States, the company focuses on entering highly regulated
markets with outsized demand potential and strong regulatory
structures.
Origin House is a growing cannabis brands and distribution
company operating across key markets in the U.S. and Canada, with a
strategic focus on becoming a preeminent global house of cannabis
brands. Origin House’s foundation is in California, the world’s
largest regulated cannabis market, where it delivers over 130
branded cannabis products from 50+ brands to many licensed
dispensaries.
_________
Signed by
Priyanka Goel, CFA
Legal Disclaimer:
This article was written by Regal Consulting, LLC (“Regal
Consulting”). Regal Consulting has agreed to a three-month
term consulting agreement with THCT dated 2/14/18. The
agreement calls for 50,000 restricted shares of THCT per month.
This agreement has been amended to $20,000 per month, and 55,000
shares per month and extended for twelve months ending 3/18/2020.
All payments were made directly by THC Therapeutics, Inc. to Regal
Consulting, LLC. to provide investor relations services, of which
this article is a part of. Regal Consulting also paid one
thousand dollars cash to microcapspeculators.com to distribute this
article. Regal Consulting may have a position in the securities
mentioned in this article at the time of publication, and may
increase or decrease its position without notice. This
article is based on public information and the opinions of Regal
Consulting. THCT was given an opportunity to edit this article.
This article contains forward-looking statements that are subject
to certain risks and uncertainties that could cause actual results
to differ materially from any results predicted herein. Regal
Consulting is not registered with any financial or securities
regulatory authority, and does not provide or claim to provide
investment advice.
http://www.regalconsultingllc.com/disclaimer/ legal
disclaimer/
Full Legal Disclaimer Click Here.
Contact Information:
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
SOURCE: Microcap Speculators